Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Nammi Therapeutics Inc
Nammi Therapeutics Inc
National Institutes of Health Clinical Center (CC)
Replimune Inc.
Shanghai Juncell Therapeutics
Indiana University
Celldex Therapeutics
National Cancer Institute (NCI)
Jiangsu HengRui Medicine Co., Ltd.
Silverback Therapeutics
Virginia Commonwealth University
IGF Oncology, LLC
University of Illinois at Chicago
Jules Bordet Institute
Poniard Pharmaceuticals
Poniard Pharmaceuticals
Pharmacyclics LLC.